Roche’s Hemlibra reduces bleeds in haemophilia A patients

20th November 2017 Uncategorised 0

Roche’s Hemlibra has hit key targets in a Phase III trial assessing its effectiveness in preventing bleeds in adults and adolescents with haemophilia A without inhibitors to factor VIII.

More: Roche’s Hemlibra reduces bleeds in haemophilia A patients
Source: News